NASS 2019 Annual Meeting

Abstract Presentations: Interdisciplinary Care (Room Room W470b)

Moderator: Eric H. Buchl, PA-C

 

74. Trends in utilization of radiotherapy for spinal meningiomas: insights from the 2004-2015 national cancer database
Yagiz U. Yolcu, MD1; Anshit Goyal, MD2; Mohammed Ali Alvi, MD2; F M Moinuddin, PhD2; Mohamad Bydon, MD2
1Rochester, MN, US; 2Mayo Clinic, Rochester, MN, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

75. Preliminary results of the prospective observational study of spinal metastasis treatment (POST)
Justin A. Blucher, MS1; Lauren Barton, BS2; Marco Ferrone, MD1; Joseph H. Schwab, MD3; James D. Kang, MD1; Mitchel Harris, MD, FACS3; Andrew J. Schoenfeld, MD1
1Brigham and Women's Hospital, Boston, MA, US; 2Boston, MA, US; 3Massachusetts General Hospital, Boston, MA, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

76. High dose radiation therapy improves survival for chordoma patients with positive surgical margins
Brian Dial, MD1; David Kerr2; Anthony Catanzano, MD2; Alexander L. Lazarides, MD2; C. Rory Goodwin, MD, PhD2; Melissa Erickson, MD2; Sergio Mendoza-Lattes, MD2
1Duke University, Durham, NC, US; 2Duke University Medical Center, Durham, NC, US>

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

77. Development of predictive models for ninety-day and one-year mortality in spinal metastatic disease
Aditya V. Karhade, MD1; Christopher M. Bono, MD2; Marco Ferrone, MD3; Philip J. Saylor, MD4; Andrew J. Schoenfeld, MD3; John H. Shin, MD2; Mitchel Harris, MD, FACS2; Joseph H. Schwab, MD2
1Harvard Medical School, Boston, MA, US; 2Massachusetts General Hospital, Boston, MA, US; 3Brigham and Women's Hospital, Boston, MA, US; 4Boston, MA, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

Discussion

 

78. Scoliosis surgery normalizes cardiac function in AIS patients
Vishal Sarwahi, MD1; Aaron M. Atlas, BS2; Rachel Gecelter3; Jesse M. Galina, BS4; Sayyida S. Hasan, BS2; Melanie Gambassi, NP5; Kathleen Maguire, MD6; Yungtai Lo, PhD7; Terry D. Amaral, MD8
1North Shore LIJ Health System, New Hyde Park, NY, US; 2Cohen Children's Medical Center, New Hyde Park, NY, US; 3Queens, NY, US; 4New Hyde Path, US; 5Northwell Health, Lake Success, NY, US; 6Montefiore Medical Center, Bronx, NY, US; 7Albert Einstein College of Medicine, Bronox, NY, US; 8Northwell Health, Lake Success, NY, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

79. The regional effect of lumbar fusion surgery on volumetric bone mineral density measured by quantitative computed tomography in adjacent vertebrae: a longitudinal cohort study
Ichiro Okano, MD1; Conor M. Jones, BA2; Stephan Salzmann, MD1; Courtney Ortiz Miller, BA1; Jennifer Shue, MS1; John A. Carrino, MD, MPH1; Andrew A. Sama, MD1; Frank P. Cammisa, MD1; Federico P. Girardi, MD1; Alexander P. Hughes, MD1
1Hospital for Special Surgery, New York, NY, US; 2New York, NY, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

80. Bariatric surgery prior to elective anterior cervical discectomy and fusion in obese patients is associated with a reduced risk of 90-day post-operative complications and readmissions
Azeem T. Malik, MBBS1; Sheldon Retchin, MD2; Wendy Xu, PhD2; Scott S. Strassels, PhD2; Elizabeth Yu, MD1; Safdar N. Khan, MD1
1The Ohio State University Wexner Medical Center, Columbus, OH, US; 2Columbus, OH, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

81. Nature of neurological deficits influences the treatment order preference for hip-spine syndrome
Kirkham B. Wood, MD1; Stuart B. Goodman, MD, PhD2; Ning Liu, MD, MPH3; Paul F. Lachiewicz, MD4
1Stanford University School of Medicine Dept. of Orthopedic Surgery, Redwood City, CA, US; 2Stanford University School of Medicine, Redwood City, CA, US; 3Stanford University, Redwood City, CA, US; 4Duke University Department of Orthopaedic Surgery, Chapel Hill, NC, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.

 

82. Bariatric surgery diminishes spinal symptoms in a morbidly obese population: a 2-year survivorship analysis of cervical and lumbar pathologies
Peter G. Passias, MD1; Haddy Alas, BS2; Avery Brown, BS2; Cole Bortz, BA3; Katherine E. Pierce, BS3; Dennis Vasquez-Montes, MS, BA2; Bassel G. Diebo, MD4; Carl B. Paulino, MD5; John Afthinos, MD6; Michael C. Gerling, MD7
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 3New York, NY, US; 4Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 5SUNY Downstate Medical Center, Brooklyn, NY, US; 6Long Island Jewish Forest Hills, Forest Hills, NY, US; 7NYU Langone, Brooklyn, Brooklyn, NY, US

 

FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.>

 

Discussion